06955 BOAN BIOTECH
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.47X | Oper Margin | 14.6% |
|---|---|---|---|
| LT Debt/Equity | 26.1% | Net Margin | 10.1% |
| Total Debt/Equity | 41.7% | Return on Equity | 4.5% |
| Price/Book | 2.66X | Return on Assets | 2.6% |
| (HKD 8.690) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 77.84 | -131.58 | -371.96 | -275.71 | -285.47 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +159.2 | +64.6 | -34.9 | +3.4 | N/A |
| Earnings Per Share (HKD) | 0.145 | -0.258 | -0.746 | -0.576 | -7.277 |
| Earnings Per Share Growth (%) | +156.2 | +65.4 | -29.5 | +92.1 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 59.85 | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 3.262 | 2.857 | 3.123 | N/A | N/A |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-12-16 21:00:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 393.41 | 362.942 | +8.4 | 261.232 |
| Operating Result | 20.514 | 61.672 | -66.7 | -119.274 |
| Profit Before Taxation | 20.514 | 61.672 | -66.7 | -119.274 |
| Taxation | 0 | 0 | N/A | 0.239 |
| Profit /( Loss) After Taxation | 20.514 | 61.672 | -66.7 | -119.513 |
| Net Profit | 20.514 | 61.672 | -66.7 | -119.513 |
| Earnings Per Share () | 0.0391 | 0.1301 | -69.9 | -0.2533 |
| Announcement Date | 2025-08-27 | 2024-08-27 | NA | 2023-08-27 |
* Annualised
Last Update Time: 2025-12-16 21:00:26
